{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:52:08Z","timestamp":1791406328309,"version":"4.3.3"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA046592"],"award-info":[{"award-number":["P30CA046592"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R37CA282790"],"award-info":[{"award-number":["R37CA282790"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society Inc","doi-asserted-by":"publisher","award":["RSG-19-003-01-CCE"],"award-info":[{"award-number":["RSG-19-003-01-CCE"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000150","name":"Office of Emerging Frontiers and Multidisciplinary Activities","doi-asserted-by":"publisher","award":["2029139"],"award-info":[{"award-number":["2029139"]}],"id":[{"id":"10.13039\/100000150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000150","name":"Office of Emerging Frontiers and Multidisciplinary Activities","doi-asserted-by":"publisher","award":["R37CA23074"],"award-info":[{"award-number":["R37CA23074"]}],"id":[{"id":"10.13039\/100000150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.actbio.2026.02.005","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:32:52Z","timestamp":1770395572000},"page":"251-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Tumoroid model recreates clinically relevant phenotypes of high grade serous ovarian cancer cells, carcinoma associated fibroblasts, and macrophages"],"prefix":"10.1016","volume":"213","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0141-5024","authenticated-orcid":false,"given":"Kathleen M.","family":"Burkhard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7598-6834","authenticated-orcid":false,"given":"Ayush","family":"Semwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin K.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina C.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riley J.","family":"Kranick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihika","family":"Rayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Analisa","family":"DiFeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5967-6425","authenticated-orcid":false,"given":"Geeta","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2026.02.005_bib0001","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00280-017-3501-8","article-title":"Advances in ovarian cancer therapy","volume":"81","author":"Cortez","year":"2018","journal-title":"Cancer Chemother Pharmacol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0002","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.actbio.2026.02.005_bib0003","doi-asserted-by":"crossref","first-page":"eabi5790","DOI":"10.1126\/sciadv.abi5790","article-title":"Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition","volume":"7","author":"Cascio","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.actbio.2026.02.005_bib0004","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.18632\/oncotarget.6870","article-title":"Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4\/HH signaling loop","volume":"7","author":"Coffman","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.actbio.2026.02.005_bib0005","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/s41591-020-0926-0","article-title":"A single-cell landscape of high-grade serous ovarian cancer","volume":"26","author":"Izar","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2026.02.005_bib0006","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s40425-019-0666-1","article-title":"Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments","volume":"7","author":"Raghavan","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.actbio.2026.02.005_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082063","article-title":"Carcinoma-associated mesenchymal stem cells promote chemoresistance in ovarian cancer stem cells via PDGF signaling","volume":"12","author":"Raghavan","year":"2020","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.actbio.2026.02.005_bib0008","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome","volume":"14","author":"Tothill","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2026.02.005_bib0009","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Bell","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2026.02.005_bib0010","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju249","article-title":"Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer","volume":"106","author":"Konecny","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.actbio.2026.02.005_bib0011","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1172\/JCI74035","article-title":"Predicting time to ovarian carcinoma recurrence using protein markers","volume":"123","author":"Yang","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.actbio.2026.02.005_bib0012","first-page":"517","article-title":"Prognostically relevant gene signatures of high-grade serous ovarian carcinoma","volume":"123","author":"Verhaak","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.actbio.2026.02.005_bib0013","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s40471-017-0115-y","article-title":"Challenges and opportunities in studying the epidemiology of ovarian cancer subtypes","volume":"4","author":"Doherty","year":"2017","journal-title":"Curr. Epidemiol. Rep."},{"key":"10.1016\/j.actbio.2026.02.005_bib0014","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/AOG.0000000000005210","article-title":"Health disparities in ovarian cancer: report from the ovarian cancer evidence review conference","volume":"142","author":"Mei","year":"2023","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0015","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1158\/1055-9965.EPI-24-0113","article-title":"Molecular subtypes of high-grade serous ovarian cancer across racial groups and gene expression platforms","volume":"33","author":"Davidson","year":"2024","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.actbio.2026.02.005_bib0016","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1158\/1078-0432.CCR-20-0103","article-title":"Development and validation of the gene expression predictor of high-grade serous ovarian carcinoma molecular SubTYPE (PrOTYPE)","volume":"26","author":"Talhouk","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2026.02.005_bib0017","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/emmm.201201823","article-title":"Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer","volume":"5","author":"Tan","year":"2013","journal-title":"EMBo Mol. Med."},{"key":"10.1016\/j.actbio.2026.02.005_bib0018","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1534\/g3.116.033514","article-title":"Comprehensive cross-population analysis of high-grade serous ovarian cancer supports no more than three subtypes","volume":"6","author":"Way","year":"2016","journal-title":"G3. (Bethesda)"},{"key":"10.1016\/j.actbio.2026.02.005_bib0019","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ccell.2021.04.004","article-title":"Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer","volume":"39","author":"Hornburg","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.actbio.2026.02.005_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109165","article-title":"Characterizing the tumor microenvironment of metastatic ovarian cancer by single-cell transcriptomics","volume":"35","author":"Olalekan","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.actbio.2026.02.005_bib0021","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1158\/0008-5472.CAN-21-3819","article-title":"Single-Cell Dissection of the Multiomic Landscape of High-Grade Serous Ovarian Cancer","volume":"82","author":"Wang","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2026.02.005_bib0022","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3389\/fonc.2019.00421","article-title":"Macrophage Polarization in the Development and Progression of Ovarian Cancers: An Overview","volume":"9","author":"Cheng","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0023","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1182\/blood-2007-02-072587","article-title":"Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells","volume":"110","author":"Duluc","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.actbio.2026.02.005_bib0024","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.4049\/jimmunol.176.8.5023","article-title":"Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype","volume":"176","author":"Hagemann","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0025","first-page":"818","article-title":"Upregulation of IGF1 by tumor-associated macrophages promotes the proliferation and migration of epithelial ovarian cancer cells","volume":"39","author":"Liu","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.actbio.2026.02.005_bib0026","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.biopha.2018.04.022","article-title":"Co-culture of ovarian cancer stem-like cells with macrophages induced SKOV3 cells stemness via IL-8\/STAT3 signaling","volume":"103","author":"Ning","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.actbio.2026.02.005_bib0027","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41419-020-2438-8","article-title":"Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C","volume":"11","author":"Steitz","year":"2020","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.actbio.2026.02.005_bib0028","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13046-019-1095-1","article-title":"Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype","volume":"38","author":"Zhu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2026.02.005_bib0029","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.actbio.2021.04.041","article-title":"Personalized models of heterogeneous 3D epithelial tumor microenvironments: Ovarian cancer as a model","volume":"132","author":"Horst","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2026.02.005_bib0030","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","article-title":"An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity","volume":"25","author":"Kopper","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2026.02.005_bib0031","doi-asserted-by":"crossref","first-page":"19714","DOI":"10.1002\/cam4.6521","article-title":"Patient-derived organoid culture in epithelial ovarian cancers-Techniques, applications, and future perspectives","volume":"12","author":"Chan","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.actbio.2026.02.005_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107762","article-title":"Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses","volume":"31","author":"de Witte","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.actbio.2026.02.005_bib0033","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69488-9","article-title":"Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing","volume":"10","author":"Nanki","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2026.02.005_bib0034","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.devcel.2023.04.012","article-title":"A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids","volume":"58","author":"Senkowski","year":"2023","journal-title":"Dev. Cell"},{"key":"10.1016\/j.actbio.2026.02.005_bib0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2015.04.014","article-title":"Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays","volume":"138","author":"Raghavan","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0036","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-0716-1956-8_15","article-title":"The role of the tumor microenvironment in CSC enrichment and chemoresistance: 3D co-culture methods","author":"Bregenzer","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0037","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-0716-3730-2_8","article-title":"Multicellular tumoroids for investigating cancer stem-like cells in the heterogeneous tumor microenvironment","author":"Burkhard","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0038","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1172\/JCI69815","article-title":"Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance","volume":"124","author":"Davidowitz","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.actbio.2026.02.005_bib0039","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jamaoncol.2023.0197","article-title":"Advances in Ovarian Cancer Care and Unmet Treatment Needs for Patients With Platinum Resistance: A Narrative Review","volume":"9","author":"Richardson","year":"2023","journal-title":"JAMa Oncol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0040","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/bjc.2012.207","article-title":"In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival","volume":"106","author":"Bicaku","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.actbio.2026.02.005_bib0041","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-1-0716-1956-8_15","article-title":"The Role of the Tumor Microenvironment in CSC Enrichment and Chemoresistance: 3D Co-culture Methods","volume":"2424","author":"Bregenzer","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0042","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11071008","article-title":"The Role of Cancer Stem Cells and Mechanical Forces in Ovarian Cancer Metastasis","volume":"11","author":"Bregenzer","year":"2019","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.actbio.2026.02.005_bib0043","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-4939-7401-6_6","article-title":"Self-Renewal and CSCs In Vitro Enrichment: Growth as Floating Spheres","volume":"1692","author":"Mehta","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0044","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612746","article-title":"Cancer Stem Cell Markers-Clinical Relevance and Prognostic Value in High-Grade Serous Ovarian Cancer (HGSOC) Based on The Cancer Genome Atlas Analysis","volume":"24","author":"I\u017cycka","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actbio.2026.02.005_bib0045","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s13402-020-00513-9","article-title":"Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles","volume":"43","author":"Yousefi","year":"2020","journal-title":"Cell Oncol. (Dordr)"},{"key":"10.1016\/j.actbio.2026.02.005_bib0046","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","article-title":"Mechanisms of transcoelomic metastasis in ovarian cancer","volume":"7","author":"Tan","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.886533","article-title":"The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination","volume":"13","author":"Ritch","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.actbio.2026.02.005_bib0048","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.164216","article-title":"A hybrid breast cancer\/mesenchymal stem cell population enhances chemoresistance and metastasis","volume":"8","author":"Augimeri","year":"2023","journal-title":"JCI. Insight."},{"key":"10.1016\/j.actbio.2026.02.005_bib0049","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1016\/j.celrep.2019.05.084","article-title":"Mesenchymal Stem\/Stromal Cell Engulfment Reveals Metastatic Advantage in Breast Cancer","volume":"27","author":"Chen","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.actbio.2026.02.005_bib0050","doi-asserted-by":"crossref","first-page":"eaat7828","DOI":"10.1126\/sciadv.aat7828","article-title":"Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival","volume":"4","author":"Gast","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.actbio.2026.02.005_bib0051","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15143725","article-title":"Cancer Associated Macrophage-like Cells Are Prognostic for Highly Aggressive Prostate Cancer in Both the Non-Metastatic and Metastatic Settings","volume":"15","author":"Gironda","year":"2023","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.actbio.2026.02.005_bib0052","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.jtho.2020.04.034","article-title":"Circulating Giant Tumor-Macrophage Fusion Cells Are Independent Prognosticators in Patients With NSCLC","volume":"15","author":"Manjunath","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0053","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314687","article-title":"Fusion Cell Markers in Circulating Tumor Cells from Patients with High-Grade Ovarian Serous Carcinoma","volume":"23","author":"Ruano","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actbio.2026.02.005_bib0054","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2026.02.005_bib0055","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1093\/nar\/gkab638","article-title":"CellCall: integrating paired ligand-receptor and transcription factor activities for cell-cell communication","volume":"49","author":"Zhang","year":"2021","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.actbio.2026.02.005_bib0056","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1158\/2159-8290.CD-17-0284","article-title":"Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers","volume":"8","author":"Pearce","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.actbio.2026.02.005_bib0057","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077166","article-title":"Smooth muscle \u03b1 actin (Acta2) and myofibroblast function during hepatic wound healing","volume":"8","author":"Rockey","year":"2013","journal-title":"PLoS. One"},{"key":"10.1016\/j.actbio.2026.02.005_bib0058","doi-asserted-by":"crossref","DOI":"10.1152\/ajplung.00210.2021","article-title":"Combined control of the fibroblast contractile program by YAP and TAZ","volume":"322","author":"Link","year":"2022","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0059","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.17.01230","article-title":"Periostin Promotes Fibroblast Migration and Inhibits Muscle Repair after Skeletal Muscle Injury","volume":"100","author":"Hara","year":"2018","journal-title":"J. Bone Joint Surg."},{"key":"10.1016\/j.actbio.2026.02.005_bib0060","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-022-00888-x","article-title":"Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-\u03baB and TGF-\u03b22 signaling","volume":"29","author":"Lin","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.actbio.2026.02.005_bib0061","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1038\/s41467-023-38093-5","article-title":"Extracellular matrix educates an immunoregulatory tumor macrophage phenotype found in ovarian cancer metastasis","volume":"14","author":"Puttock","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2026.02.005_bib0062","doi-asserted-by":"crossref","first-page":"eabm1831","DOI":"10.1126\/sciadv.abm1831","article-title":"Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer","volume":"8","author":"Zhang","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.actbio.2026.02.005_bib0063","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2026.02.005_bib0064","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/bph.16257","article-title":"Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer","volume":"181","author":"Gy\u0151rffy","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0065","doi-asserted-by":"crossref","DOI":"10.1007\/s11357-023-00742-4","article-title":"Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer","volume":"45","author":"Gy\u0151rffy","year":"2023","journal-title":"Geroscience"},{"key":"10.1016\/j.actbio.2026.02.005_bib0066","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00647","article-title":"Are Epithelial Ovarian Cancers of the Mesenchymal Subtype Actually Intraperitoneal Metastases to the Ovary?","volume":"8","author":"Hu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0067","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.jcmgh.2021.01.008","article-title":"Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages","volume":"11","author":"Samain","year":"2021","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0068","doi-asserted-by":"crossref","first-page":"82482","DOI":"10.18632\/oncotarget.12694","article-title":"Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models","volume":"7","author":"Wolfe","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.actbio.2026.02.005_bib0069","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s41419-019-2131-y","article-title":"Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer","volume":"10","author":"Li","year":"2019","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.actbio.2026.02.005_bib0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s11658-021-00273-w","article-title":"Macrophage polarization by MSC-derived CXCL12 determines tumor growth","volume":"26","author":"Babazadeh","year":"2021","journal-title":"Cell Mol. Biol. Lett."},{"key":"10.1016\/j.actbio.2026.02.005_bib0071","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.4049\/jimmunol.1900692","article-title":"Exosomes Produced by Mesenchymal Stem Cells Drive Differentiation of Myeloid Cells into Immunosuppressive M2-Polarized Macrophages in Breast Cancer","volume":"203","author":"Biswas","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0072","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1158\/1078-0432.CCR-17-0133","article-title":"Personalized Medicine-Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids","volume":"23","author":"Raghavan","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2026.02.005_bib0073","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neo.2019.06.005","article-title":"Engineered 3D Model of Cancer Stem Cell Enrichment and Chemoresistance","volume":"21","author":"Ward Rashidi","year":"2019","journal-title":"Neoplasia"},{"key":"10.1016\/j.actbio.2026.02.005_bib0074","doi-asserted-by":"crossref","DOI":"10.3791\/59696","article-title":"Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells","author":"Bregenzer","year":"2019","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.actbio.2026.02.005_bib0075","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.7659","article-title":"Comparative analysis of tumor spheroid generation techniques for differential in vitro drug toxicity","author":"Raghavan","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.actbio.2026.02.005_bib0076","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116215","article-title":"Spheroid Formation and Peritoneal Metastasis in Ovarian Cancer: The Role of Stromal and Immune Components","volume":"23","author":"Rakina","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actbio.2026.02.005_bib0077","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/s41388-018-0523-6","article-title":"Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth","volume":"38","author":"McLean","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.actbio.2026.02.005_bib0078","doi-asserted-by":"crossref","DOI":"10.1593\/neo.08672","article-title":"SPARC ameliorates ovarian cancer-associated inflammation","volume":"10","author":"Said","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.actbio.2026.02.005_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115152","article-title":"The response and resistance to drugs in ovarian cancer cell lines in 2D monolayers and 3D spheroids","volume":"165","author":"\u015awierczewska","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.actbio.2026.02.005_bib0080","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1158\/1078-0432.CCR-11-2188","article-title":"Stem cell pathways contribute to clinical chemoresistance in ovarian cancer","volume":"18","author":"Steg","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2026.02.005_bib0081","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1158\/1535-7163.MCT-10-0563","article-title":"Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer","volume":"9","author":"Landen","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.actbio.2026.02.005_bib0082","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/cc.8.1.7533","article-title":"Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance","volume":"8","author":"Alvero","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.actbio.2026.02.005_bib0083","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/stem.154","article-title":"Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells","volume":"27","author":"Kurrey","year":"2009","journal-title":"Stem Cells (1981)"},{"key":"10.1016\/j.actbio.2026.02.005_bib0084","doi-asserted-by":"crossref","first-page":"55771","DOI":"10.18632\/oncotarget.9908","article-title":"Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer","volume":"7","author":"Deng","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.actbio.2026.02.005_bib0085","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1158\/0008-5472.CAN-10-3175","article-title":"Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival","volume":"71","author":"Silva","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2026.02.005_bib0086","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11040502","article-title":"A Novel ALDH1A1 Inhibitor Targets Cells with Stem Cell Characteristics in Ovarian Cancer","volume":"11","author":"Nwani","year":"2019","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.actbio.2026.02.005_bib0087","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.762820","article-title":"Disulfiram Transcends ALDH Inhibitory Activity When Targeting Ovarian Cancer Tumor-Initiating Cells","volume":"12","author":"Caminear","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112009","article-title":"ALDH1A1+ ovarian cancer stem cells co-expressing surface markers CD24, EPHA1 and CD9 form tumours in vivo","volume":"392","author":"Nagare","year":"2020","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.actbio.2026.02.005_bib0089","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ygyno.2024.01.045","article-title":"Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FR\u03b1)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer","volume":"185","author":"Richardson","year":"2024","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0090","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003973","article-title":"Tumor-associated macrophages induced spheroid formation by CCL18-ZEB1-M-CSF feedback loop to promote transcoelomic metastasis of ovarian cancer","volume":"9","author":"Long","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.actbio.2026.02.005_bib0091","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3892\/ijo.2015.3122","article-title":"Interleukin-6 expression by interactions between gynecologic cancer cells and human mesenchymal stem cells promotes epithelial-mesenchymal transition","volume":"47","author":"So","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0092","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1080\/15384047.2018.1564567","article-title":"M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression","volume":"20","author":"Zeng","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.actbio.2026.02.005_bib0093","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.15252\/emmm.201404208","article-title":"Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients","volume":"6","author":"Tan","year":"2014","journal-title":"EMBo Mol. Med."},{"key":"10.1016\/j.actbio.2026.02.005_bib0094","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ygyno.2013.09.034","article-title":"The Wnt\/beta-catenin pathway in ovarian cancer: a review","volume":"131","author":"Arend","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0095","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1158\/0008-5472.CAN-19-1601","article-title":"Host Wnt5a Potentiates Microenvironmental Regulation of Ovarian Cancer Metastasis","volume":"80","author":"Asem","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2026.02.005_bib0096","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41698-023-00495-5","article-title":"Cancer associated fibroblasts serve as an ovarian cancer stem cell niche through noncanonical Wnt5a signaling","volume":"8","author":"Fang","year":"2024","journal-title":"NPJ. Precis. Oncol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0097","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1158\/1541-7786.MCR-23-0616","article-title":"ROR2\/Wnt5a Signaling Regulates Directional Cell Migration and Early Tumor Cell Invasion in Ovarian Cancer","volume":"22","author":"Grither","year":"2024","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.actbio.2026.02.005_bib0098","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144458","article-title":"ARID3A and ARID3B induce stem promoting pathways in ovarian cancer cells","volume":"738","author":"Dausinas","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.actbio.2026.02.005_bib0099","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1158\/0008-5472.CAN-20-0458","article-title":"EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells","volume":"80","author":"Zong","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2026.02.005_bib0100","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1158\/0008-5472.CAN-08-0943","article-title":"Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells","volume":"68","author":"Mishra","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2026.02.005_bib0101","doi-asserted-by":"crossref","first-page":"e4992","DOI":"10.1371\/journal.pone.0004992","article-title":"Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression","volume":"4","author":"Spaeth","year":"2009","journal-title":"PLoS. One"},{"key":"10.1016\/j.actbio.2026.02.005_bib0102","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ng.3225","article-title":"Stromal gene expression defines poor-prognosis subtypes in colorectal cancer","volume":"47","author":"Calon","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.actbio.2026.02.005_bib0103","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.798680","article-title":"CAF-associated paracrine signaling worsens outcome and potentially contributes to chemoresistance in epithelial ovarian cancer","volume":"12","author":"Wessolly","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0104","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1158\/0008-5472.CAN-14-3569","article-title":"CD73 is associated with poor prognosis in high-grade serous ovarian cancer","volume":"75","author":"Turcotte","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2026.02.005_bib0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.923194","article-title":"Single-Cell RNA-Sequencing Atlas Reveals the Tumor Microenvironment of Metastatic High-Grade Serous Ovarian Carcinoma","volume":"13","author":"Deng","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0106","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2011.05.011","article-title":"Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancer","volume":"150","author":"Arafat","year":"2011","journal-title":"Surgery."},{"key":"10.1016\/j.actbio.2026.02.005_bib0107","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.2147\/IJGM.S463649","article-title":"Unveiling Collagen\u2019s Role in Breast Cancer: Insights into Expression Patterns, Functions and Clinical Implications","volume":"17","author":"Li","year":"2024","journal-title":"Int. J. Gen. Med. Volume"},{"key":"10.1016\/j.actbio.2026.02.005_bib0108","doi-asserted-by":"crossref","DOI":"10.14701\/ahbps.2020.24.1.52","article-title":"Prognostic value of COL6A3 in pancreatic adenocarcinoma","volume":"24","author":"Svoronos","year":"2020","journal-title":"Ann. Hepatobiliary. Pancreat. Surg."},{"key":"10.1016\/j.actbio.2026.02.005_bib0109","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010029","article-title":"CREB3L1 facilitates pancreatic tumor progression and reprograms intratumoral tumor-associated macrophages to shape an immunotherapy-resistance microenvironment","volume":"13","author":"Xu","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.actbio.2026.02.005_bib0110","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.12141","article-title":"Comprehensive analysis of abnormal expression, prognostic value and oncogenic role of the hub gene FN1 in pancreatic ductal adenocarcinoma via bioinformatic analysis and in vitro experiments","volume":"9","author":"Lei","year":"2021","journal-title":"PeerJ."},{"key":"10.1016\/j.actbio.2026.02.005_bib0111","doi-asserted-by":"crossref","DOI":"10.1007\/s00438-022-01943-w","article-title":"FN1 encoding fibronectin as a pivotal signaling gene for therapeutic intervention against pancreatic cancer","volume":"297","author":"Ashok","year":"2022","journal-title":"Mol. Genet. Genomics"},{"key":"10.1016\/j.actbio.2026.02.005_bib0112","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2018.1484734","article-title":"A feature-based analysis identifies COL1A2 as a regulator in pancreatic cancer","volume":"34","author":"Wu","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.actbio.2026.02.005_bib0113","article-title":"COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer","volume":"55","author":"Owusu-Ansah","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.actbio.2026.02.005_bib0114","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154013","article-title":"COL1A1: a novel oncogenic gene and therapeutic target in malignancies","volume":"236","author":"Li","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.actbio.2026.02.005_bib0115","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-023-07032-9","article-title":"FN1 mediated activation of aspartate metabolism promotes the progression of triple-negative and luminal a breast cancer","volume":"201","author":"Chen","year":"2023","journal-title":"Breast. Cancer Res. Treat."},{"key":"10.1016\/j.actbio.2026.02.005_bib0116","article-title":"FN1 overexpression is correlated with unfavorable prognosis and immune infiltrates in breast cancer","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.actbio.2026.02.005_bib0117","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-022-06569-5","article-title":"Targeting HIF1-alpha\/miR-326\/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer","volume":"193","author":"Assidicky","year":"2022","journal-title":"Breast. Cancer Res. Treat."},{"key":"10.1016\/j.actbio.2026.02.005_bib0118","doi-asserted-by":"crossref","DOI":"10.2147\/OTT.S256818","article-title":"A six-epithelial\u2013mesenchymal transition gene signature may predict metastasis of triple-negative breast cancer","volume":"13","author":"Wei","year":"2020","journal-title":"Onco Targets. Ther."},{"key":"10.1016\/j.actbio.2026.02.005_bib0119","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/biomedicines13010168","article-title":"Immunotherapy in Recurrent Ovarian Cancer","volume":"13","author":"Chen","year":"2025","journal-title":"Biomedicines."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126000784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126000784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:06:35Z","timestamp":1791403595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706126000784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":119,"alternative-id":["S1742706126000784"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2026.02.005","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumoroid model recreates clinically relevant phenotypes of high grade serous ovarian cancer cells, carcinoma associated fibroblasts, and macrophages","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2026.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Acta Materialia Inc.","name":"copyright","label":"Copyright"}]}}